James A. Schoeneck
2015 - DepoMed
In 2015, James A. Schoeneck earned a total compensation of $6.3M as Former President and Chief Executive Officer at DepoMed, a 56% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $800,000 |
---|---|
Option Awards | $2,374,601 |
Salary | $708,333 |
Stock Awards | $2,430,180 |
Other | $16,808 |
Total | $6,329,922 |
Schoeneck received $2.4M in stock awards, accounting for 38% of the total pay in 2015.
Schoeneck also received $800K in non-equity incentive plan, $2.4M in option awards, $708.3K in salary and $16.8K in other compensation.
Rankings
In 2015, James A. Schoeneck's compensation ranked 1,149th out of 13,638 executives tracked by ExecPay. In other words, Schoeneck earned more than 91.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,149 out of 13,638 | 92nd |
Division Manufacturing | 408 out of 5,190 | 92nd |
Major group Chemicals And Allied Products | 147 out of 1,854 | 92nd |
Industry group Drugs | 113 out of 1,528 | 93rd |
Industry Pharmaceutical Preparations | 92 out of 1,182 | 92nd |
Source: SEC filing on July 14, 2017.
Schoeneck's colleagues
We found four more compensation records of executives who worked with James A. Schoeneck at DepoMed in 2015.